Habitual coffee consumption and risk of type 2 diabetes, ischemic heart disease, depression and Alzheimer's disease: A Mendelian randomization study

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Kwok, Man Ki ^a   Leung, Gabriel M ^a   Schooling, C Mary ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALZHEIMER DISEASE; COFFEE; DEPRESSION; FEMALE; GENETICS; HEART MUSCLE ISCHEMIA; HUMAN; MALE; MENDELIAN RANDOMIZATION ANALYSIS; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALZHEIMER DISEASE; COFFEE; DEPRESSION; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MENDELIAN RANDOMIZATION ANALYSIS; MIDDLE AGED; MYOCARDIAL ISCHEMIA; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84995489488     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep36500     Document Type: Article

References (63)

1. National Coffee Association. National Coffee Drinking Trends 2010, http://www. ncausa. org/Industry-Resources/Market-Research/National-Coffee-Drinking-Trends-Report (Date of access: April 28, 2016) (2010).
2. Michaud, D. S. et al. Coffee and tea intake and risk of brain tumors in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study. Am J Clin Nutr 92, 1145-1150, doi: 10. 3945/ajcn. 2010. 29876 (2010).
3. Institute for Scientific Information on Coffee. Can drinking coffee be healthy Beliefs and behaviours across Europe, http://coffeeandhealth. org/wp-content/uploads/2016/01/Coffee-and-a-Healthy-Diet-European-Infographic-FINAL-1. pdf (2016). (Date of access: April 28, 2016).
4. United States Department of Health and Human Services & United States Department of Agriculture. 2015-2020 Dietary Guidelines for Americans. 8th Edition. http://health. gov/dietaryguidelines/2015/guidelines/(Date of access: May 16, 2016) (2015).
5. Ding, M., Bhupathiraju, S. N., Chen, M., van Dam, R. M., Hu, F. B. Caffeinated and decaffeinated coffee consumption and risk of type 2 diabetes: a systematic review and a dose-response meta-analysis. Diabetes Care 37, 569-586, doi: 10. 2337/dc13-1203 (2014).
6. Liu, Q. P. et al. Habitual coffee consumption and risk of cognitive decline/dementia: A systematic review and meta-analysis of prospective cohort studies. Nutrition 32, 628-636, doi: 10. 1016/j. nut. 2015. 11. 015 (2016).
7. Guo, X. et al. Sweetened beverages, coffee, and tea and depression risk among older US adults. PLoS One 9, e94715, doi: 10. 1371/journal. pone. 0094715 (2014).
8. Grosso, G., Micek, A., Castellano, S., Pajak, A., Galvano, F. Coffee, tea, caffeine and risk of depression: A systematic review and dose-response meta-analysis of observational studies. Mol Nutr Food Res 60, 223-234, doi: 10. 1002/mnfr. 201500620 (2016).
9. Wu, J. N. et al. Coffee consumption and risk of coronary heart diseases: a meta-analysis of 21 prospective cohort studies. Int J Cardiol 137, 216-225, doi: 10. 1016/j. ijcard. 2008. 06. 051 (2009).
10. Ding, M., Bhupathiraju, S. N., Satija, A., van Dam, R. M., Hu, F. B. Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose-response meta-analysis of prospective cohort studies. Circulation 129, 643-659, doi: 10. 1161/CIRCULATIONAHA. 113. 005925 (2014).
11. Cai, L., Ma, D., Zhang, Y., Liu, Z., Wang, P. The effect of coffee consumption on serum lipids: a meta-analysis of randomized controlled trials. Eur J Clin Nutr 66, 872-877, doi: 10. 1038/ejcn. 2012. 68 (2012).
12. Wedick, N. M. et al. Effects of caffeinated and decaffeinated coffee on biological risk factors for type 2 diabetes: a randomized controlled trial. Nutr J 10, 93, doi: 10. 1186/1475-2891-10-93 (2011).
13. Persson, J. et al. Sex-Specific Effects of Adiponectin on Carotid Intima-Media Thickness and Incident Cardiovascular Disease. J Am Heart Assoc 4, e001853, doi: 10. 1161/JAHA. 115. 001853 (2015).
14. Ohnaka, K. et al. Effects of 16-week consumption of caffeinated and decaffeinated instant coffee on glucose metabolism in a randomized controlled trial. J Nutr Metab 2012, 207426, doi: 10. 1155/2012/207426 (2012).
15. Correa, T. A. et al. Paper-filtered coffee increases cholesterol and inflammation biomarkers independent of roasting degree: a clinical trial. Nutrition 29, 977-981, doi: 10. 1016/j. nut. 2013. 01. 003 (2013).
16. Kempf, K. et al. Cardiometabolic effects of two coffee blends differing in content for major constituents in overweight adults: a randomized controlled trial. Eur J Nutr 54, 845-854, doi: 10. 1007/s00394-014-0763-3 (2015).
17. Lawlor, D. A., Harbord, R. M., Sterne, J. A., Timpson, N., Davey Smith, G. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 27, 1133-1163, doi: 10. 1002/sim. 3034 (2008).
18. Nordestgaard, A. T., Thomsen, M., Nordestgaard, B. G. Coffee intake and risk of obesity, metabolic syndrome and type 2 diabetes: a Mendelian randomization study. Int J Epidemiol 44, 551-565, doi: 10. 1093/ije/dyv083 (2015).
19. Drewnowski, A., Rehm, C. D. Sources of Caffeine in Diets of US Children and Adults: Trends by Beverage Type and Purchase Location. Nutrients 8, doi: 10. 3390/nu8030154 (2016).
20. The Coffee and Caffeine Genetics Consortium et al. Genome-wide meta-analysis identifies six novel loci associated with habitual coffee consumption. Mol Psychiatry 20, 647-656, doi: 10. 1038/mp. 2014. 107 (2015).
21. Cornelis, M. C. et al. Genome-wide meta-analysis identifies regions on 7p21 (AHR) and 15q24 (CYP1A2) as determinants of habitual caffeine consumption. PLoS Genet 7, e1002033, doi: 10. 1371/journal. pgen. 1002033 (2011).
22. Amin, N. et al. Genome-wide association analysis of coffee drinking suggests association with CYP1A1/CYP1A2 and NRCAM. Mol Psychiatry 17, 1116-1129, doi: 10. 1038/mp. 2011. 101 (2012).
23. Ebrahim, S., Davey Smith, G. Mendelian randomization: can genetic epidemiology help redress the failures of observational epidemiology Hum Genet 123, 15-33, doi: 10. 1007/s00439-007-0448-6 (2008).
24. Mattar, R., de Campos Mazo, D. F., Carrilho, F. J. Lactose intolerance: diagnosis, genetic, and clinical factors. Clin Exp Gastroenterol 5, 113-121, doi: 10. 2147/CEG. S32368 (2012).
25. Haycock, P. C. et al. Best (but oft-forgotten) practices: the design, analysis, and interpretation of Mendelian randomization studies. Am J Clin Nutr 103, 965-978, doi: 10. 3945/ajcn. 115. 118216 (2016).
26. Pierce, B. L., Burgess, S. Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators. Am J Epidemiol 178, 1177-1184, doi: 10. 1093/aje/kwt084 (2013).
27. CARDIoGRAMplusC4D Consortium et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet 45, 25-33, doi:10. 1038/ng. 2480 (2013).
28. Schunkert, H. et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 43, 333-338, doi: 10. 1038/ng. 784 (2011).
29. Morris, A. P. et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet 44, 981-990, doi: 10. 1038/ng. 2383 (2012).
30. Major Depressive Disorder Working Group of the Psychiatric Gwas Consortium et al. A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry 18, 497-511, doi: 10. 1038/mp. 2012. 21 (2013).
31. Lambert, J. C. et al. Meta-analysis of 74, 046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet 45, 1452-1458, doi: 10. 1038/ng. 2802 (2013).
32. Ritchie, K. et al. The neuroprotective effects of caffeine: a prospective population study (the Three City Study). Neurology 69, 536-545, doi: 10. 1212/01. wnl. 0000266670. 35219. 0c (2007).
33. Global Lipids Genetics Consortium et al. Discovery and refinement of loci associated with lipid levels. Nat Genet 45, 1274-1283, doi: 10. 1038/ng. 2797 (2013).
34. Scott, R. A. et al. Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet 44, 991-1005, doi: 10. 1038/ng. 2385 (2012).
35. Soranzo, N. et al. Common variants at 10 genomic loci influence hemoglobin A(1)(C) levels via glycemic and nonglycemic pathways. Diabetes 59, 3229-3239, doi: 10. 2337/db10-0502 (2010).
36. Schooling, C. M., Au Yeung, S. L., Freeman, G. Mendelian randomization estimates may be inflated. J Am Coll Cardiol 61, 1931, doi: 10. 1016/j. jacc. 2012. 12. 049 (2013).
37. Burgess, S. et al. Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors. Eur J Epidemiol 30, 543-552, doi: 10. 1007/s10654-015-0011-z (2015).
38. Moran, A. E. et al. Variations in ischemic heart disease burden by age, country, and income: the Global Burden of Diseases, Injuries, and Risk Factors 2010 study. Glob Heart 9, 91-99, doi:10. 1016/j. gheart. 2013. 12. 007 (2014).
39. Danaei, G. et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2. 7 million participants. Lancet 378, 31-40, doi: 10. 1016/S0140-6736(11)60679-X (2011).
40. Fulgoni, V. L. 3rd, Keast, D. R., Lieberman, H. R. Trends in intake and sources of caffeine in the diets of US adults: 2001-2010. Am J Clin Nutr 101, 1081-1087, doi: 10. 3945/ajcn. 113. 080077 (2015).
41. Schooling, C. M., Freeman, G., Cowling, B. J. Mendelian randomization and estimation of treatment efficacy for chronic diseases. Am J Epidemiol 177, 1128-1133, doi: 10. 1093/aje/kws344 (2013).
42. Davey Smith, G., Ebrahim, S. Mendelian randomization: prospects, potentials, and limitations. Int J Epidemiol 33, 30-42, doi: 10. 1093/ije/dyh132 (2004).
43. Strandhagen, E., Thelle, D. S. Filtered coffee raises serum cholesterol: results from a controlled study. Eur J Clin Nutr 57, 1164-1168, doi: 10. 1038/sj. ejcn. 1601668 (2003).
44. Rowland, A., Mangoni, A. A. Cytochrome P450 and ischemic heart disease: current concepts and future directions. Expert Opin Drug Metab Toxicol 10, 191-213, doi: 10. 1517/17425255. 2014. 859675 (2014).
45. Dragin, N. et al. Phenotype of the Cyp1a1/1a2/1b1-/-triple-knockout mouse. Mol Pharmacol 73, 1844-1856, doi: 10. 1124/mol. 108. 045658 (2008).
46. Wada, T. et al. Aryl Hydrocarbon Receptor Plays Protective Roles against High Fat Diet (HFD)-induced Hepatic Steatosis and the Subsequent Lipotoxicity via Direct Transcriptional Regulation of Socs3 Gene Expression. J Biol Chem 291, 7004-7016, doi: 10. 1074/jbc. M115. 693655 (2016).
47. Nikpay, M. et al. A comprehensive 1, 000 Genomes-based genome-wide association meta-analysis of coronary artery disease. Nat Genet 47, 1121-1130, doi: 10. 1038/ng. 3396 (2015).
48. Solfrizzi, V. et al. Coffee Consumption Habits and the Risk of Mild Cognitive Impairment: The Italian Longitudinal Study on Aging. J Alzheimers Dis 47, 889-899, doi: 10. 3233/JAD-150333 (2015).
49. Solfrizzi, V. et al. Lifestyle-related factors in predementia and dementia syndromes. Expert Rev Neurother 8, 133-158, doi: 10. 1586/14737175. 8. 1. 133 (2008).
50. Panza, F. et al. Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: a systematic review. J Nutr Health Aging 19, 313-328, doi: 10. 1007/s12603-014-0563-8 (2015).
51. Santos, C., Costa, J., Santos, J., Vaz-Carneiro, A., Lunet, N. Caffeine intake and dementia: systematic review and meta-analysis. J Alzheimers Dis 20 Suppl 1, S187-S204, doi: 10. 3233/JAD-2010-091387 (2010).
52. Araujo, L. F. et al. Association of Coffee Consumption with MRI Markers and Cognitive Function: A Population-Based Study. J Alzheimers Dis, doi: 10. 3233/JAD-160116 (2016).
53. Linder, A. E. et al. Vascular reactivity, 5-HT uptake, and blood pressure in the serotonin transporter knockout rat. Am J Physiol Heart Circ Physiol 294, H1745-H1752, doi: 10. 1152/ajpheart. 91415. 2007 (2008).
54. Tajeddinn, W. et al. Association of Platelet Serotonin Levels in Alzheimer's Disease with Clinical and Cerebrospinal Fluid Markers. J Alzheimers Dis, doi: 10. 3233/JAD-160022 (2016).
55. Higdon, J. V., Frei, B. Coffee and health: a review of recent human research. Crit Rev Food Sci Nutr 46, 101-123, doi: 10. 1080/10408390500400009 (2006).
56. Oboh, G., Agunloye, O. M., Akinyemi, A. J., Ademiluyi, A. O., Adefegha, S. A. Comparative study on the inhibitory effect of caffeic and chlorogenic acids on key enzymes linked to Alzheimer's disease and some pro-oxidant induced oxidative stress in rats' brainin vitro. Neurochem Res 38, 413-419, doi: 10. 1007/s11064-012-0935-6 (2013).
57. Dupuis, J. et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42, 105-116, doi: 10. 1038/ng. 520 (2010).
58. Locke, A. E. et al. Genetic studies of body mass index yield new insights for obesity biology. Nature 518, 197-206, doi: 10. 1038/nature14177 (2015).
59. Shungin, D. et al. New genetic loci link adipose and insulin biology to body fat distribution. Nature 518, 187-196, doi: 10. 1038/nature14132 (2015).
60. Dastani, Z. et al. Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic metaanalysis of 45, 891 individuals. PLoS Genet 8, e1002607, doi: 10. 1371/journal. pgen. 1002607 (2012).
61. Benyamin, B. et al. Childhood intelligence is heritable, highly polygenic and associated with FNBP1L. Mol Psychiatry 19, 253-258, doi: 10. 1038/mp. 2012. 184 (2014).
62. Burgess, S., Dudbridge, F., Thompson, S. G. Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods. Stat Med 35, 1880-1906, doi: 10. 1002/sim. 6835 (2016).
63. Han, B. et al. A general framework for meta-analyzing dependent studies with overlapping subjects in association mapping. Hum Mol Genet, 1-10, doi: 10. 1093/hmg/ddw049 (2016).